TL;DR
This study introduces a novel mouse model (C57BL/6 <sup>Aire-/-</sup>) that recapitulates the chronic, non-resolving inflammation and immune dysregulation observed in human benign prostatic hyperplasia (BPH). By comparing single-cell RNA sequencing data from these mice with human BPH samples, the researchers identified striking similarities in immune cell populations and fibroblast characteristics, validating this model for future BPH research.
What Problem Does This Paper Address?
Benign prostatic hyperplasia (BPH) is a common, age-related condition in men that causes significant morbidity, yet its underlying causes remain largely unknown. While chronic inflammation is suspected to play a crucial role in BPH development and progression, existing animal models have limitations in fully capturing the complex interplay of immune cells and stromal components seen in human BPH. Specifically, there's a need for a model that exhibits persistent, localized prostatic inflammation without systemic autoimmunity, allowing for a deeper understanding of how immune dysregulation drives prostatic hyperplasia.
Methods
The researchers utilized a combination of techniques to characterize their novel BPH model:
- Animal Model: They employed C57BL/6 <sup>Aire-/-</sup> mice, which have a deficiency in the Autoimmune Regulator (Aire) gene. This deficiency leads to a loss of central tolerance and can induce autoimmunity, but in this specific context, it was leveraged to create localized prostatic inflammation through immunization with prostate homogenate and Freund's Adjuvant.
- Histology: Standard H&E staining and immunohistochemistry were used to visualize the cellular architecture and immune cell infiltration in prostate tissues.
- Flow Cytometry: This technique was used to quantify specific immune cell populations within the prostates.
- Single-Cell RNA Sequencing (scRNA-seq): This was the core technology used to comprehensively profile the transcriptomes of individual cells within the prostate. This allowed for the identification of distinct cell types, their states, and their gene expression patterns.
- Bioinformatics Analysis: scRNA-seq data was analyzed using tools like Seurat and SingleR for cell clustering, cell type annotation, and differential gene expression analysis. Interaction analysis was performed to predict communication between different cell types.
Datasets
The study utilized the following datasets:
- Newly generated scRNA-seq data: From C57BL/6 <sup>Aire-/-</sup> mouse prostates harvested at 21 and 35 days post-immunization.
- Publicly available scRNA-seq data: From human BPH prostates (references 10 and 14).
- Reference datasets: For cell type annotation using SingleR, specifically the Immunological Genome Project reference.
- Previously published datasets: For comparison of fibroblast populations from wild-type mice and human donors.
Key Insights and Ideas
- Aire knockout as a targeted inflammation driver: The key insight is that by using an Aire knockout mouse and specific immunization, the researchers could induce chronic, localized prostatic inflammation without widespread systemic autoimmunity, making it a more relevant model for BPH.
- Mirroring human BPH immune landscape: The most significant finding is the striking similarity between the immune cell composition (T cells, B cells, macrophages) and fibroblast profiles in the C57BL/6 <sup>Aire-/-</sup> mouse model and human BPH tissues. This suggests the model effectively captures key aspects of the human disease.
- Identification of specific cell populations: The study identified specific macrophage populations (e.g., Trem2+) and aging-associated T cell subsets (GZMK<sup>hi</sup> GZMB<sup>low</sup> CD8<sup>+</sup> T cells) in the mouse model that are also found in human BPH, providing potential targets for further investigation.
- Fibroblast senescence and aging: The research highlighted that fibroblasts in the Aire knockout mouse prostates exhibit markers associated with aging and senescence, mirroring observations in human BPH, suggesting a role for inflammaging in the disease.
Key Results
- Chronic Prostatic Inflammation: C57BL/6 <sup>Aire-/-</sup> mice developed persistent, localized inflammation in their prostates following immunization, which was not observed in control mice or in other organs.
- Dominant Immune Cell Types: scRNA-seq and histology revealed that B and T lymphocytes were the dominant leukocyte populations in the inflamed prostates, similar to human BPH.
- Macrophage Phenotypes: Macrophages in the mouse model displayed a range of phenotypes, including Trem2<sup>+</sup> populations, and showed signatures similar to those found in human BPH macrophages.
- Aging-Associated T Cells: The study identified CD8<sup>+</sup> T cells with a GZMK<sup>hi</sup> GZMB<sup>low</sup> profile, analogous to aging-associated T cells (Taa) found in human BPH.
- Fibroblast Similarity: Fibroblast clusters in the mouse model closely resembled those found in human BPH prostates, with shared expression of aging-associated markers.
- No Timepoint Shift: Cellular composition and gene expression showed minimal differences between prostates harvested at 21 and 35 days post-booster, suggesting a stable inflammatory state within this timeframe.
Limitations and Future Work
- Mast Cell Discrepancy: A notable difference was the lower proportion of mast cells in the mouse model compared to human BPH, which might limit research on mast cell roles in BPH using this model. The authors suggest this could be an inherent mouse-human difference or due to digestion protocols.
- Human Heterogeneity: The authors acknowledge that human BPH is heterogeneous, and digestion protocol differences may contribute to observed discrepancies between mouse and human data.
- Future Work: The authors propose further comparisons with other animal models of BPH and detailed investigations into specific aspects like fibrosis, stromal proliferation, and immune cell infiltration. They also suggest using this model to study age-related inflammatory processes (inflammaging) and the role of myeloid cell dysfunction in BPH progression. The limited sample size for timepoint comparisons warrants further study.
Summary updated